The purpose of this study was to evaluate radiosurgical outcomes in skull base chordomas and chondrosarcomas, and to determine which tumors are appropriate for stereotactic radiosurgery as adjuvant therapy following maximum tumor resection.
Thirty-seven patients (48 lesions) were treated using Gamma Knife surgery (GKS); 27 had chordomas, seven had chondrosarcomas, and three had radiologically diagnosed chordomas. The mean tumor volume was 20 ml, and the mean maximum and marginal doses were 28 and 14 Gy, respectively. The mean follow-up period was 97 months from diagnosis and 59 months from GKS.
The actuarial 5- and 10-year survival rates after GKS were 80 and 53%, respectively. The actuarial 5- and 10-year local tumor control (LTC) rates after single or multiple GKS sessions were 76 and 67%, respectively. All patients with low-grade chondrosarcomas achieved good LTC. A tumor volume of less than 20 ml significantly affected the high rate of LTC (p = 0.0182). No patient had adverse radiation effects, other than one in whom facial numbness worsened despite successful tumor control.
As an adjuvant treatment after resection, GKS is a reasonable option for selected patients harboring skull base chordomas or chondrosarcomas with a residual tumor volume of less than 20 ml. Dose planning with a generous treatment volume to avoid marginal treatment failure should be made at a marginal dose of at least 15 Gy to achieve long-term tumor control.
Abbreviations used in this paper:GKS = Gamma Knife surgery; LTC = local tumor control; MR = magnetic resonance; PFS = progression-free survival.
Address correspondence to: Toshinori Hasegawa, M.D., Department of Neurosurgery, Gamma Knife Center, Komaki City Hospital, 1–20 Jobushi, Komaki, Aichi Prefecture, 485-8520, Japan. email:
BersonAMCastroJRPettiPPhillipsTLGaugerGEGutinP: Charged particle irradiation of chordoma and chondrosarcoma of the base of skull and cervical spine: the Lawrence Berkeley Laboratory experience. Int J Radiat Oncol Biol Phys15:559–5651988
FagundesMAHugEBLiebschNJDalyWEfirdJMunzenriderJE: Radiation therapy for chordomas of the base of skull and cervical spine: pattern of failure and outcome after relapse. Int J Radiat Oncol Biol Phys33:579–5841995
NoelGHabrandJMammarHPontvertDHaie-MederCHasbounD: Combination of photon and proton radiation therapy for chordomas and chondrosarcomas of the skull base: the Centre de Protontherapie D'orsay experience. Int J Radiat Oncol Biol Phys51:392–3982001
SantoniRLiebschNFinkelsteinDMHugEHanssensPGoiteinM: Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull. Int J Radiat Oncol Biol Phys41:59–681998
TeraharaANiemierkoAGoiteinMFinkelsteinDHugELiebschN: Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. Int J Radiat Oncol Biol Phys45:351–3581999